ENDOTHELIAL MATRIX IN ATHEROGENESIS
ENDOTHELIAL MATRIX IN ATHEROGENESIS
批准号:
6030858
负责人:
Kevin Jon Williams
金额:
$30.64万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-15 至 2002-06-30
关键词:
RNase protection assay apolipoprotein B atherosclerosis chondroitin sulfates clinical research cytokine gene expression gene targeting genetic polymorphism genetically modified animals glycoprotein biosynthesis heart catheterization human genetic material tag human subject hypoxia laboratory mouse low density lipoprotein mechanical stress oxidized lipid pathologic process proteoglycan single strand conformation polymorphism sulfotransferase tissue /cell culture vascular endothelium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The key instigating event that provokes a normal artery to become
atherosclerotic appears to be the sub-endothelial retention of apoB-rich
lipoproteins by arterial matrix. In this proposal, we will examine the
role known to avidly bind apoB-rich lipoproteins. To allow a molecular
approach, we have cloned, sequenced, and expressed the human cDNA for
chondroitin-6-sulfotransferase (C6ST), the key enzyme in C6S biosynthesis.
We have documented expression in human endothelial cells and obtained and
characterized genomic clones.
Aim I: Regulation of endothelial proteoglycan assembly and function in
vitro. We will focus on four regulatory stimuli, each of which changes
proteoglycan structure and has been linked to atherogenesis: shear stress,
hypoxia, oxidized lipoproteins, and cytokines. Proteoglycan assembly by
cultured endothelial cells will be assessed by the C6:C4 sulfate ration,
expression of C6ST mRNA & protein, C6ST mRNA transcription & stability,
C6ST phosphorylation & subcellular distribution, and expression of C6ST
promoter constructs. Proteoglycan function will be assessed by affinity
co-electrophoresis (ACE) gels to establish binding constructs to human
LDL, and by our cell-culture model of lipoprotein retention.
Aim II: Atherogenesis in endothelial-specific C6ST transgenics. To
directly examine the effects of endothelial matrix variations on
atherogenesis in vivo, we propose to create C6ST transgenics with
expression limited to large-vessel endothelium. Distribution of C6ST
message and protein will be examined microscopically, and aortic
proteoglycans will be assessed as described in Aim I. Retention of LDL in
aortae ex vivo and in vivo, endothelial function, and atherosclerotic
lesion development after crossing to hyperlipidemic apoE knock-out mice
will then be determined.
Aim III: The role of C6ST in human disease. We will determine the
distribution of C6ST message and protein in normal and atherosclerotic
human arteries: screen for C6ST polymorphisms in patients proven by
cardiac catheterization to be with or without disease; & test linkage of
the C6ST locus with a disease of low C6S.
Overall, these proposed studied will substantially enhanced our
understanding of endothelial matrix assembly, which is likely to
contribute to the large variation in atherosclerotic lesion development
between arterial sites and amongst individuals with similar plasma lipid
profiles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia
-
批准号:8613570
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2013
-
负责人:Kevin Jon Williams
-
依托单位:
Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia
-
批准号:8735948
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2013
-
负责人:Kevin Jon Williams
-
依托单位:
Sulfatase-2: Key mediator of atherogenic postprandial dyslipoproteinemia
-
批准号:9308939
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2013
-
负责人:Kevin Jon Williams
-
依托单位:
Screens for novel compounds to correct diabetic postprandial dyslipidemia
-
批准号:8129732
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
HSPGs as remnant receptors: critical role in diabetic postprandial dyslipidemia
-
批准号:7729570
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
Screens for novel compounds to correct diabetic postprandial dyslipidemia
-
批准号:7919401
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
HSPGs as remnant receptors: critical role in diabetic postprandial dyslipidemia
-
批准号:7919405
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
HSPGs as remnant receptors: critical role in diabetic postprandial dyslipidemia
-
批准号:8309295
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
Screens for novel compounds to correct diabetic postprandial dyslipidemia
-
批准号:7651625
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
HSPGs as remnant receptors: critical role in diabetic postprandial dyslipidemia
-
批准号:8123127
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Kevin Jon Williams
-
依托单位:
Endocytic Trafficking Motifs in Syndecan & LDL receptor
-
批准号:7056775
-
项目类别:
-
资助金额:$30.47万
-
财政年份:2005
-
负责人:Kevin Jon Williams
-
依托单位:
Endocytic Trafficking Motifs in Syndecan & LDL receptor
-
批准号:7895223
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2005
-
负责人:Kevin Jon Williams
-
依托单位:
Endocytic Trafficking Motifs in Syndecan & LDL receptor
-
批准号:7234006
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2005
-
负责人:Kevin Jon Williams
-
依托单位:
Endocytic Trafficking Motifs in Syndecan & LDL receptor
-
批准号:6927521
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2005
-
负责人:Kevin Jon Williams
-
依托单位:
Endocytic Trafficking Motifs in Syndecan & LDL receptor
-
批准号:7414002
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2005
-
负责人:Kevin Jon Williams
-
依托单位:
Transmigration of HIV-1-infected cells in NeuroAIDS
-
批准号:6893204
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2004
-
负责人:Kevin Jon Williams
-
依托单位:
Transmigration of HIV-1-infected cells in NeuroAIDS
-
批准号:6998960
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2004
-
负责人:Kevin Jon Williams
-
依托单位:
ENDOTHELIAL MATRIX IN ATHEROGENESIS
-
批准号:6183334
-
项目类别:
-
资助金额:$31.48万
-
财政年份:1998
-
负责人:Kevin Jon Williams
-
依托单位:
ENDOTHELIAL MATRIX IN ATHEROGENESIS
-
批准号:2692686
-
项目类别:
-
资助金额:$31.38万
-
财政年份:1998
-
负责人:Kevin Jon Williams
-
依托单位:
ENDOTHELIAL MATRIX IN ATHEROGENESIS
-
批准号:6389742
-
项目类别:
-
资助金额:$32.34万
-
财政年份:1998
-
负责人:Kevin Jon Williams
-
依托单位:
海外基金